HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: clinchem.2008.110593v1 54/12/1969    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (1) Citing Articles via Google Scholar Google Scholar Articles by Nybo, M. Articles by Rasmussen, L. M. Search for Related Content PubMed PubMed Citation Articles by Nybo, M. Articles by Rasmussen, L. M.

Lack of Observed Association between High Plasma Osteoprotegerin Concentrations and Ischemic Stroke Risk in a Healthy Population

¹ Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Odense, Denmark; ² Department of Clinical Epidemiology, Aarhus University Hospital, Denmark; ³ Center for Cardiovascular Research, Aalborg Hospital, Aarhus University Hospital, Denmark; ⁴ Department of Cardiology, Aalborg Hospital, Aarhus University Hospital, Denmark; ⁵ Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; ⁶ Institute of Experimental Clinical Research, Aarhus University Hospital, Denmark.

^aAddress correspondence to this author at: Department of Biochemistry, Pharmacology and Genetics, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense, Denmark. Fax +45 6541 1911; e-mail mads.nybo{at}ouh.regionsyddanmark.dk

Background: Several studies suggest that osteoprotegerin (OPG) concentrations may be associated with the risk of ischemic stroke, but no large prospective studies have been conducted. We conducted a nested case-control study within a large cohort to elucidate a possible relation.

Methods: The study was done within a follow-up study including 57 053 men and women. Baseline data included OPG concentrations, lifestyle factors, and medical history. Median length of follow-up was 3.1 years. We assessed the relationship between OPG and stroke risk using conditional logistic regression to adjust for known risk factors (smoking, blood pressure, cholesterol, diabetes, body mass index, alcohol use, polyunsaturated fatty acids, and education).

Results: We identified 254 cases with verified incident acute ischemic stroke and 254 age- and sex-matched controls. Median plasma OPG concentration among cases was 1.84 µg/L (25th–75th percentile 1.45–2.30 µg/L) compared with 1.87 µg/L (1.49–2.27 µg/L) in the control group. The adjusted odds ratio was 0.87 (95% CI 0.46–1.63) comparing participants in the highest quartile of OPG concentrations with those in the lowest quartile.

Conclusions: These findings provide no support for the hypothesis that plasma OPG concentrations are associated with an increased risk of ischemic stroke. This result could indicate a different pathogenic process in stroke development from that in ischemic heart disease, where OPG is a strong predictor.

The following articles in journals at HighWire Press have cited this article:

				G. M. Jorgensen, B. Vind, M. Nybo, L. M. Rasmussen, and K. Hojlund Acute hyperinsulinemia decreases plasma osteoprotegerin with diminished effect in type 2 diabetes and obesity Eur. J. Endocrinol., July 1, 2009; 161(1): 95 - 101. [Abstract] [Full Text] [PDF]

				M. D. Hill What Kind of Stroke Is It? Clin. Chem., December 1, 2008; 54(12): 1943 - 1944. [Full Text] [PDF]